The cervical cancer vaccine is the HPV vaccine, and for sexually active women who have not participated in an effective cervical cancer screening prior to receiving the bivalent HPV vaccine, HPV as well as TCT tests are performed prior to vaccination. The bivalent HPV vaccine is designed to prevent infection with HPV type 16 and HPV type 18 viruses, thereby preventing cervical cancer and warts. Before administering the vaccine, the doctor will routinely ask about any history of allergies, illnesses, sexual activity, etc., and determine if the patient is suitable for the vaccine based on his or her condition. The bivalent HPV vaccine can prevent cervical cancer, and HPV and TCT tests can help detect cervical cancer in time for early treatment. Moreover, regular screening is needed after vaccination. In addition, after the bivalent vaccine, you need to stay for thirty minutes and inform your doctor if you have any discomfort such as rash or dizziness.